Efficacy from the phase 1 study of FID-007, a novel nanoparticle paclitaxel formulation, in patients with head and neck squamous cell carcinoma.

albumin-bound paclitaxel - Generic mfg.

nanoencapsulated paclitaxel (FID-007) - ANP Technologies, Fulgent Genetics

Erbitux (cetuximab) - Eli Lilly, EMD Serono

https://meetings.asco.org/abstracts-presentations/234827/

Lydia D. Chow; Robert Hsu; Jorge J. Nieva; Rebecca Umayam; Angela Smith Bryant; Denice Tsao-Wei; Ming Hsieh; Ray Yin; Anthony B. El-Khoueiry; Jacob Stephen Thomas

Apr 25, 2024